Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arcadia Biosciences, Inc. (RKDA) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Arcadia Biosciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1469443.
Total stock buying since 2015: $22,339,231.
Total stock sales since 2015: $1,761,248.
Total stock option exercises since 2015: $867,057.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 1,400 | $3,486 | 0 | $0 | 0 | $0 |
| 2024 | 2,100 | $4,326 | 0 | $0 | 0 | $0 |
| 2023 | 6,349 | $24,091 | 0 | $0 | 0 | $0 |
| 2022 | 700 | $489 | 0 | $0 | 0 | $0 |
| 2020 | 4,085 | $9,884 | 0 | $0 | 0 | $0 |
| 2019 | 33,100 | $193,205 | 0 | $0 | 0 | $0 |
| 2018 | 0 | $0 | 28,005 | $1,189,110 | 28,005 | $610,708 |
| 2017 | 5,000 | $3,750 | 5,950 | $1,356 | 0 | $0 |
| 2016 | 0 | $0 | 21,092 | $58,386 | 7,892 | $8,522 |
| 2015 | 2,762,500 | $22,100,000 | 130,021 | $512,396 | 428,000 | $247,827 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-02 | 1,400 | $3,486 | 0 | $0 | 0 | $0 |
| 2024-08 | 1,400 | $2,884 | 0 | $0 | 0 | $0 |
| 2024-02 | 700 | $1,442 | 0 | $0 | 0 | $0 |
| 2023-08 | 649 | $2,381 | 0 | $0 | 0 | $0 |
| 2023-05 | 5,000 | $21,549 | 0 | $0 | 0 | $0 |
| 2023-02 | 700 | $161 | 0 | $0 | 0 | $0 |
| 2022-08 | 700 | $489 | 0 | $0 | 0 | $0 |
| 2020-08 | 1,985 | $6,272 | 0 | $0 | 0 | $0 |
| 2020-02 | 2,100 | $3,612 | 0 | $0 | 0 | $0 |
| 2019-12 | 900 | $5,355 | 0 | $0 | 0 | $0 |
| 2019-11 | 7,000 | $29,850 | 0 | $0 | 0 | $0 |
| 2019-09 | 25,200 | $158,000 | 0 | $0 | 0 | $0 |
| 2018-03 | 0 | $0 | 28,005 | $1,189,110 | 28,005 | $610,708 |
| 2017-11 | 0 | $0 | 5,950 | $1,356 | 0 | $0 |
| 2017-06 | 5,000 | $3,750 | 0 | $0 | 0 | $0 |
| 2016-08 | 0 | $0 | 100 | $250 | 100 | $108 |
| 2016-06 | 0 | $0 | 8,280 | $20,642 | 0 | $0 |
| 2016-04 | 0 | $0 | 4,573 | $12,668 | 2,853 | $3,081 |
| 2016-03 | 0 | $0 | 3,273 | $10,475 | 3,273 | $3,534 |
| 2016-02 | 0 | $0 | 4,866 | $14,351 | 1,666 | $1,799 |
| 2015-12 | 0 | $0 | 25,035 | $95,919 | 52,500 | $32,700 |
| 2015-11 | 0 | $0 | 4,527 | $13,191 | 23,000 | $12,040 |
| 2015-10 | 0 | $0 | 35,881 | $110,326 | 141,351 | $104,592 |
| 2015-09 | 0 | $0 | 64,578 | $292,960 | 211,149 | $98,495 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-03 | Kawakami Mark (Chief Financial Officer) | Buy | 700 | 2.49 | 1,743 |
| 2025-02-03 | Schaefer Thomas J. (Chief Executive Officer) | Buy | 700 | 2.49 | 1,743 |
| 2024-08-01 | Kawakami Mark (Chief Financial Officer) | Buy | 700 | 2.06 | 1,442 |
| 2024-08-01 | Schaefer Thomas J. (Chief Executive Officer) | Buy | 700 | 2.06 | 1,442 |
| 2024-02-01 | Schaefer Thomas J. (Chief Financial Officer) | Buy | 700 | 2.06 | 1,442 |
| 2023-08-04 | Schaefer Thomas J. (Chief Financial Officer) | Buy | 649 | 3.67 | 2,381 |
| 2023-05-30 | Jacot Stanley Jr (Chief Executive Officer) | Buy | 5,000 | 4.31 | 21,549 |
| 2023-02-01 | Schaefer Thomas J. (Chief Financial Officer) | Buy | 700 | .23 | 161 |
| 2022-08-01 | Haley Pamela (Chief Financial Officer) | Buy | 700 | .70 | 489 |
| 2020-08-03 | Shultz Randall (Chief Technology Officer) | Buy | 700 | 3.16 | 2,212 |
| 2020-08-03 | Haley Pamela (Chief Financial Officer) | Buy | 700 | 3.16 | 2,212 |
| 2020-08-03 | Plavan Matthew T (Chief Executive Officer) | Buy | 585 | 3.16 | 1,848 |
| 2020-02-03 | Haley Pamela (Chief Financial Officer) | Buy | 700 | 1.72 | 1,204 |
| 2020-02-03 | Reiter Sarah (Chief Commercial Officer) | Buy | 700 | 1.72 | 1,204 |
| 2020-02-03 | Plavan Matthew T (Chief Executive Officer) | Buy | 700 | 1.72 | 1,204 |
| 2019-12-23 | Reiter Sarah (Chief Commercial Officer) | Buy | 900 | 5.95 | 5,355 |
| 2019-11-19 | Reiter Sarah (Chief Commercial Officer) | Buy | 1,000 | 4.52 | 4,520 |
| 2019-11-18 | Murray Lilian Shackelford (Director) | Buy | 5,000 | 4.25 | 21,250 |
| 2019-11-14 | Plavan Matthew T (Chief Executive Officer) | Buy | 1,000 | 4.08 | 4,080 |
| 2019-09-23 | Plavan Matthew T (Chief Executive Officer) | Buy | 2,000 | 5.25 | 10,500 |
| 2019-09-17 | Comcowich Kevin (Director) | Buy | 5,000 | 5.88 | 29,390 |
| 2019-09-10 | Reiter Sarah (Chief Commercial Officer) | Buy | 1,200 | 6.48 | 7,776 |
| 2019-09-10 | Comcowich Kevin (Director) | Buy | 15,000 | 6.49 | 97,320 |
| 2019-09-10 | Plavan Matthew T (Chief Executive Officer) | Buy | 2,000 | 6.51 | 13,014 |
| 2018-03-23 | Lu Zhongjin (VP Product Development) | Sale | 1,750 | 32.74 | 57,295 |
| 2018-03-23 | Lu Zhongjin (VP Product Development) | Option Ex | 1,750 | 21.60 | 37,800 |
| 2018-03-23 | Rey Eric J. (Director) | Sale | 5,000 | 33.44 | 167,200 |
| 2018-03-23 | Rey Eric J. (Director) | Option Ex | 5,000 | 21.60 | 108,000 |
| 2018-03-15 | Rey Eric J. (Director) | Sale | 250 | 60.00 | 15,000 |
| 2018-03-15 | Rey Eric J. (Director) | Option Ex | 250 | 44.80 | 11,200 |
| 2018-03-14 | Rey Eric J. (Director) | Sale | 21,005 | 45.21 | 949,615 |
| 2018-03-14 | Rey Eric J. (Director) | Option Ex | 21,005 | 21.60 | 453,708 |
| 2017-11-17 | Lu Zhongjin (VP Product Development) | Sale | 5,950 | .23 | 1,356 |
| 2017-06-08 | Rey Eric J. (Director) | Buy | 5,000 | .75 | 3,750 |
| 2016-08-04 | Salameh Roger (Chief Operating Officer) | Sale | 100 | 2.51 | 250 |
| 2016-08-04 | Salameh Roger (Chief Operating Officer) | Option Ex | 100 | 1.08 | 108 |
| 2016-06-13 | Brandwein Steven F. (Interim Chief Financ. Officer) | Sale | 8,280 | 2.49 | 20,642 |
| 2016-04-25 | Brandwein Steven F. (Interim Chief Financ. Officer) | Sale | 1,720 | 2.42 | 4,169 |
| 2016-04-05 | Knauf Vic C. (Chief Scientific Officer) | Sale | 1,653 | 2.98 | 4,929 |
| 2016-04-05 | Knauf Vic C. (Chief Scientific Officer) | Option Ex | 1,653 | 1.08 | 1,785 |
| 2016-04-04 | Knauf Vic C. (Chief Scientific Officer) | Sale | 1,200 | 2.98 | 3,570 |
| 2016-04-04 | Knauf Vic C. (Chief Scientific Officer) | Option Ex | 1,200 | 1.08 | 1,296 |
| 2016-03-04 | Knauf Vic C. (Chief Scientific Officer) | Sale | 2,973 | 3.22 | 9,584 |
| 2016-03-04 | Knauf Vic C. (Chief Scientific Officer) | Option Ex | 2,973 | 1.08 | 3,210 |
| 2016-03-03 | Knauf Vic C. (Chief Scientific Officer) | Sale | 300 | 2.97 | 891 |
| 2016-03-03 | Knauf Vic C. (Chief Scientific Officer) | Option Ex | 300 | 1.08 | 324 |
| 2016-02-03 | Rey Eric J. (President and CEO) | Sale | 200 | 2.78 | 556 |
| 2016-02-01 | Rey Eric J. (President and CEO) | Sale | 3,000 | 2.93 | 8,793 |
| 2016-02-01 | Knauf Vic C. (Chief Scientific Officer) | Sale | 1,666 | 3.00 | 5,002 |
| 2016-02-01 | Knauf Vic C. (Chief Scientific Officer) | Option Ex | 1,666 | 1.08 | 1,799 |
| 2015-12-15 | Brandwein Steven F. (Interim Chief Financ. Officer) | Sale | 10,035 | 3.57 | 35,784 |
| 2015-12-15 | Brandwein Steven F. (Interim Chief Financ. Officer) | Option Ex | 37,500 | .44 | 16,500 |
| 2015-12-02 | Knauf Vic C. (Chief Scientific Officer) | Sale | 8,700 | 4.10 | 35,635 |
| 2015-12-02 | Knauf Vic C. (Chief Scientific Officer) | Option Ex | 8,700 | 1.08 | 9,396 |
| 2015-12-01 | Knauf Vic C. (Chief Scientific Officer) | Sale | 6,300 | 3.89 | 24,500 |
| 2015-12-01 | Knauf Vic C. (Chief Scientific Officer) | Option Ex | 6,300 | 1.08 | 6,804 |
| 2015-11-11 | Rey Eric J. (President and CEO) | Option Ex | 3,000 | 1.08 | 3,240 |
| 2015-11-11 | Knauf Vic C. (Chief Scientific Officer) | Sale | 4,527 | 2.91 | 13,191 |
| 2015-11-11 | Knauf Vic C. (Chief Scientific Officer) | Option Ex | 20,000 | .44 | 8,800 |
| 2015-10-09 | Rey Eric J. (President and CEO) | Sale | 5,145 | 3.01 | 15,471 |
| 2015-10-09 | Rey Eric J. (President and CEO) | Option Ex | 15,782 | .44 | 6,944 |
| 2015-10-08 | Rey Eric J. (President and CEO) | Sale | 1,500 | 2.99 | 4,482 |
| 2015-10-08 | Rey Eric J. (President and CEO) | Option Ex | 4,555 | .44 | 2,004 |
| 2015-10-07 | Rey Eric J. (President and CEO) | Sale | 3,500 | 3.00 | 10,510 |
| 2015-10-07 | Rey Eric J. (President and CEO) | Option Ex | 10,764 | .44 | 4,736 |
| 2015-10-06 | Rey Eric J. (President and CEO) | Sale | 4,100 | 3.28 | 13,448 |
| 2015-10-06 | Rey Eric J. (President and CEO) | Option Ex | 12,614 | .44 | 5,550 |
| 2015-10-05 | Rey Eric J. (President and CEO) | Sale | 14,136 | 3.15 | 44,542 |
| 2015-10-05 | Rey Eric J. (President and CEO) | Option Ex | 45,078 | .44 | 19,834 |
| 2015-10-02 | Rey Eric J. (President and CEO) | Sale | 2,900 | 2.99 | 8,662 |
| 2015-10-02 | Rey Eric J. (President and CEO) | Option Ex | 9,259 | .44 | 4,073 |
| 2015-10-02 | Brandwein Steven F. (VP Finance and Administration) | Option Ex | 10,000 | 1.08 | 10,800 |
| 2015-10-01 | Rey Eric J. (President and CEO) | Sale | 4,600 | 2.87 | 13,211 |
| 2015-10-01 | Rey Eric J. (President and CEO) | Option Ex | 13,299 | .44 | 5,851 |
| 2015-10-01 | Reis James Richard (Director) | Option Ex | 20,000 | 2.24 | 44,800 |
| 2015-09-30 | Rey Eric J. (President and CEO) | Sale | 5,800 | 3.17 | 18,386 |
| 2015-09-30 | Rey Eric J. (President and CEO) | Option Ex | 15,967 | .44 | 7,025 |
| 2015-09-29 | Rey Eric J. (President and CEO) | Sale | 3,900 | 3.52 | 13,716 |
| 2015-09-29 | Rey Eric J. (President and CEO) | Option Ex | 11,406 | .44 | 5,018 |
| 2015-09-28 | Rey Eric J. (President and CEO) | Sale | 6,200 | 3.69 | 22,847 |
| 2015-09-28 | Rey Eric J. (President and CEO) | Option Ex | 16,884 | .44 | 7,428 |
| 2015-09-25 | Rey Eric J. (President and CEO) | Sale | 10,000 | 4.03 | 40,270 |
| 2015-09-25 | Rey Eric J. (President and CEO) | Option Ex | 26,971 | .44 | 11,867 |
| 2015-09-24 | Rey Eric J. (President and CEO) | Sale | 7,089 | 4.32 | 30,652 |
| 2015-09-24 | Rey Eric J. (President and CEO) | Option Ex | 19,095 | .44 | 8,401 |
| 2015-09-23 | Rey Eric J. (President and CEO) | Sale | 4,000 | 4.80 | 19,208 |
| 2015-09-23 | Rey Eric J. (President and CEO) | Option Ex | 10,826 | .44 | 4,763 |
| 2015-09-14 | Emlay Don (VP Regulatory and Compliance) | Sale | 689 | 4.81 | 3,311 |
| 2015-09-14 | Emlay Don (VP Regulatory and Compliance) | Option Ex | 2,015 | .44 | 886 |
| 2015-09-11 | Salameh Roger (VP Business Development) | Sale | 1,648 | 4.92 | 8,104 |
| 2015-09-11 | Salameh Roger (VP Business Development) | Option Ex | 4,603 | .44 | 2,025 |
| 2015-09-11 | Emlay Don (VP Regulatory and Compliance) | Sale | 2,284 | 4.92 | 11,232 |
| 2015-09-11 | Emlay Don (VP Regulatory and Compliance) | Option Ex | 6,397 | .44 | 2,814 |
| 2015-09-11 | Lu Zhongjin (VP Product Development) | Sale | 1,068 | 4.92 | 5,252 |
| 2015-09-11 | Lu Zhongjin (VP Product Development) | Option Ex | 2,958 | .44 | 1,301 |
| 2015-09-10 | Salameh Roger (VP Business Development) | Sale | 1,575 | 5.27 | 8,301 |
| 2015-09-10 | Salameh Roger (VP Business Development) | Option Ex | 4,448 | .44 | 1,957 |
| 2015-09-10 | Emlay Don (VP Regulatory and Compliance) | Sale | 548 | 5.27 | 2,888 |
| 2015-09-10 | Emlay Don (VP Regulatory and Compliance) | Option Ex | 1,588 | .44 | 698 |
| 2015-09-10 | Lu Zhongjin (VP Product Development) | Sale | 1,302 | 5.27 | 6,862 |
| 2015-09-10 | Lu Zhongjin (VP Product Development) | Option Ex | 3,685 | .44 | 1,621 |
| 2015-09-10 | Knauf Vic C. (Chief Scientific Officer) | Sale | 575 | 5.27 | 3,030 |
| 2015-09-10 | Knauf Vic C. (Chief Scientific Officer) | Option Ex | 2,238 | .44 | 984 |
| 2015-09-09 | Salameh Roger (VP Business Development) | Sale | 2,765 | 5.55 | 15,334 |
| 2015-09-09 | Salameh Roger (VP Business Development) | Option Ex | 8,115 | .44 | 3,570 |
| 2015-09-09 | Lu Zhongjin (VP Product Development) | Sale | 2,370 | 5.55 | 13,144 |
| 2015-09-09 | Lu Zhongjin (VP Product Development) | Option Ex | 6,975 | .44 | 3,069 |
| 2015-09-09 | Knauf Vic C. (Chief Scientific Officer) | Sale | 2,765 | 5.55 | 15,334 |
| 2015-09-09 | Knauf Vic C. (Chief Scientific Officer) | Option Ex | 11,129 | .44 | 4,896 |
| 2015-09-09 | Wong Mark (Director) | Option Ex | 5,000 | .44 | 2,200 |
| 2015-09-09 | Reis James Richard (Director) | Option Ex | 17,500 | .76 | 13,300 |
| 2015-09-08 | Salameh Roger (VP Business Development) | Sale | 3,500 | 5.51 | 19,281 |
| 2015-09-08 | Salameh Roger (VP Business Development) | Option Ex | 10,334 | .44 | 4,546 |
| 2015-09-08 | Lu Zhongjin (VP Product Development) | Sale | 3,000 | 5.51 | 16,527 |
| 2015-09-08 | Lu Zhongjin (VP Product Development) | Option Ex | 8,882 | .44 | 3,908 |
| 2015-09-08 | Knauf Vic C. (Chief Scientific Officer) | Sale | 3,500 | 5.51 | 19,281 |
| 2015-09-08 | Knauf Vic C. (Chief Scientific Officer) | Option Ex | 14,133 | .44 | 6,218 |
| 2015-05-20 | Gujadhur Sheokumar (10% Owner) | Buy | 375,000 | 8.00 | 3,000,000 |
| 2015-05-20 | John G. Sperling 2012 Irrevocable Trust No. 3 (10% Owner) | Buy | 1,000,000 | 8.00 | 8,000,000 |
| 2015-05-20 | Garg Uday (Director) | Buy | 375,000 | 8.00 | 3,000,000 |
| 2015-05-20 | Shupp Darby E (Director) | Buy | 1,000,000 | 8.00 | 8,000,000 |
| 2015-05-20 | Reis James Richard (Director) | Buy | 12,500 | 8.00 | 100,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of RKDA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Arcadia Biosciences, Inc. (symbol RKDA, CIK number 1469443) see the Securities and Exchange Commission (SEC) website.